Bessemer Group Inc Novartis Ag Transaction History

Bessemer Group Inc

  • $61.3 Billion
  • Q4 2024

A detailed history of Bessemer Group Inc transactions in Novartis Ag stock. As of the latest transaction made, Bessemer Group Inc holds 10,184 shares of NVS stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,184
Previous 11,374 10.46%
Holding current value
$1.11 Million
Previous $1.31 Million 24.24%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$96.78 - $117.18 $115,168 - $139,444
-1,190 Reduced 10.46%
10,184 $991,000
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $110,375 - $125,725
-1,040 Reduced 8.38%
11,374 $1.31 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $14,718 - $17,071
-159 Reduced 1.26%
12,414 $1.32 Million
Q1 2024

May 13, 2024
SELL
$95.27 - $108.47 $228,457 - $260,111
-2,398 Reduced 16.02%
12,573 $1.22 Million
Q4 2023

Feb 09, 2024
BUY
$92.27 - $101.54 $24,267 - $26,705
263 Added 1.79%
14,971 $1.51 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $158,672 - $176,092
-1,675 Reduced 10.22%
14,708 $1.5 Million
Q2 2023

Aug 10, 2023
BUY
$92.52 - $104.91 $74,756 - $84,767
808 Added 5.19%
16,383 $1.65 Million
Q1 2023

May 10, 2023
SELL
$80.03 - $92.81 $111,401 - $129,191
-1,392 Reduced 8.2%
15,575 $1.43 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $379,940 - $465,283
-5,029 Reduced 22.86%
16,967 $1.54 Million
Q3 2022

Nov 09, 2022
BUY
$74.61 - $87.26 $310,302 - $362,914
4,159 Added 23.32%
21,996 $1.67 Million
Q2 2022

Aug 10, 2022
SELL
$80.52 - $93.75 $21,015 - $24,468
-261 Reduced 1.44%
17,837 $1.51 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $172,476 - $195,104
-2,153 Reduced 10.63%
18,098 $1.59 Million
Q4 2021

Jan 27, 2022
SELL
$79.7 - $88.13 $105,443 - $116,595
-1,323 Reduced 6.13%
20,251 $1.77 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $40,153 - $46,713
-491 Reduced 2.23%
21,574 $1.76 Million
Q2 2021

Aug 06, 2021
BUY
$85.24 - $94.15 $68,447 - $75,602
803 Added 3.78%
22,065 $2.01 Million
Q1 2021

May 13, 2021
BUY
$83.5 - $98.47 $550,599 - $649,311
6,594 Added 44.96%
21,262 $1.82 Million
Q4 2020

Feb 09, 2021
BUY
$78.07 - $94.43 $26,075 - $31,539
334 Added 2.33%
14,668 $1.39 Million
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $43,205 - $47,866
526 Added 3.81%
14,334 $1.25 Million
Q2 2020

Aug 05, 2020
SELL
$80.93 - $91.1 $70,651 - $79,530
-873 Reduced 5.95%
13,808 $1.21 Million
Q1 2020

Apr 30, 2020
SELL
$70.67 - $99.01 $14,346 - $20,099
-203 Reduced 1.36%
14,681 $1.21 Million
Q4 2019

Feb 04, 2020
SELL
$84.35 - $95.37 $33,740 - $38,148
-400 Reduced 2.62%
14,884 $1.41 Million
Q3 2019

Nov 07, 2019
BUY
$85.54 - $94.26 $276,978 - $305,213
3,238 Added 26.88%
15,284 $1.33 Million
Q2 2019

Jul 19, 2019
BUY
$75.4 - $92.8 $34,080 - $41,945
452 Added 3.9%
12,046 $1.1 Million
Q1 2019

May 13, 2019
SELL
$75.32 - $86.15 $148,305 - $169,629
-1,969 Reduced 14.52%
11,594 $1.11 Million
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $195,493 - $217,681
2,654 Added 24.33%
13,563 $1.16 Million
Q3 2018

Nov 06, 2018
SELL
$66.94 - $77.43 $19,546 - $22,609
-292 Reduced 2.61%
10,909 $940,000
Q2 2018

Jul 25, 2018
SELL
$64.91 - $73.36 $45,372 - $51,278
-699 Reduced 5.87%
11,201 $846,000
Q1 2018

May 10, 2018
SELL
$70.39 - $84.15 $75,246 - $89,956
-1,069 Reduced 8.24%
11,900 $963,000
Q4 2017

Jan 30, 2018
SELL
$72.33 - $77.64 $159,053 - $170,730
-2,199 Reduced 14.5%
12,969 $1.09 Million
Q3 2017

Nov 03, 2017
BUY
$74.14 - $77.27 $1.12 Million - $1.17 Million
15,168
15,168 $1.3 Million

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email